Affordable Access

deepdyve-link
Publisher Website

Prognostic value of total triiodothyronine and free thyroxine levels for the heart failure in patients with acute myocardial infarction.

Authors
  • Kang, Min Gyu1
  • Hahm, Jong Ryeal2
  • Kim, Kye-Hwan1
  • Park, Hyun-Woong1
  • Koh, Jin-Sin1
  • Hwang, Seok-Jae1
  • Hwang, Jin-Yong1
  • Ahn, Jong Hwa3
  • Park, Yongwhi3
  • Jeong, Young-Hoon3
  • Park, Jeong Rang1
  • Kwak, Choong Hwan3
  • 1 Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea. , (North Korea)
  • 2 Division of Endocrinology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea. , (North Korea)
  • 3 Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, Korea. , (North Korea)
Type
Published Article
Journal
The Korean journal of internal medicine
Publication Date
May 01, 2018
Volume
33
Issue
3
Pages
512–521
Identifiers
DOI: 10.3904/kjim.2016.292
PMID: 28073241
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Although a low triiodothyronine (T3) state is closely associated with heart failure (HF), it is uncertain whether total T3 levels on admission is correlated with the clinical outcomes of acute myocardial infarction (AMI). The aim of this study is to investigate the prognostic value of total T3 levels for major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with AMI undergone percutaneous coronary intervention (PCI). A total of 765 PCI-treated AMI patients (65.4 ± 12.6 years old, 215 women) between January 2012 and July 2014 were included and 1-year MACCEs were analyzed. We assessed the correlation of total T3 and free thyroxine (fT4) with prevalence of 1-year MACCEs and the predictive values of total T3, fT4, and the ratio of total T3 to fT4 (T3/fT4), especially for HF requiring re-hospitalization. Thirty patients (3.9%) were re-hospitalized within 12 months to control HF symptoms. Total T3 levels were lower in the HF group than in the non-HF group (84.32 ± 21.04 ng/dL vs. 101.20 ± 20.30 ng/dL, p < 0.001). Receiver operating characteristic curve analysis showed the cut-offs of total T3 levels (≤ 85 ng/dL) and T3/fT4 (≤ 60) for HF (area under curve [AUC] = 0.734, p < 0.001; AUC = 0.774, p < 0.001, respectively). In multivariate analysis, lower T3/fT4 was an independent predictor for 1-year HF in PCI-treated AMI patients (odds ratio, 1.035; 95% confidential interval, 1.007 to 1.064; p = 0.015). Lower levels of total T3 were well correlated with 1-year HF in PCI-treated AMI patients. The T3/fT4 levels can be an additional marker to predict HF.

Report this publication

Statistics

Seen <100 times